Warning! GuruFocus detected
1 Severe warning sign
with POLB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Poolbeg Pharma PLC
ISIN : GB00BKPG7Z60
Share Class Description:
LSE:POLB: Ordinary SharesDescription
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 2.72 | |||||
| 9-Day RSI | 7.24 | |||||
| 14-Day RSI | 14.2 | |||||
| 3-1 Month Momentum % | -31.94 | |||||
| 6-1 Month Momentum % | -53.77 | |||||
| 12-1 Month Momentum % | -47.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.61 | |||||
| Quick Ratio | 19.61 | |||||
| Cash Ratio | 17.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -30.23 | |||||
| ROA % | -28.86 | |||||
| ROIC % | -163.86 | |||||
| ROCE % | -35.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 1.38 | |||||
| EV-to-EBIT | -0.72 | |||||
| EV-to-Forward-EBIT | -2.09 | |||||
| EV-to-EBITDA | -0.72 | |||||
| EV-to-Forward-EBITDA | -2.09 | |||||
| EV-to-FCF | -1.19 | |||||
| Price-to-Net-Current-Asset-Value | 1.38 | |||||
| Price-to-Net-Cash | 1.38 | |||||
| Earnings Yield (Greenblatt) % | -139.09 | |||||
| FCF Yield % | -33.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poolbeg Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ÂŁ) | |||
| EPS (TTM) (ÂŁ) | -0.009 | ||
| Beta | 2.08 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 45.96 | ||
| 14-Day RSI | 14.2 | ||
| 14-Day ATR (ÂŁ) | 0.003315 | ||
| 20-Day SMA (ÂŁ) | 0.04027 | ||
| 12-1 Month Momentum % | -47.87 | ||
| 52-Week Range (ÂŁ) | 0.027 - 0.15767 | ||
| Shares Outstanding (Mil) | 500 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poolbeg Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poolbeg Pharma PLC Stock Events
| Event | Date | Price (ÂŁ) | ||
|---|---|---|---|---|
| No Event Data | ||||
Poolbeg Pharma PLC Frequently Asked Questions
What is Poolbeg Pharma PLC(LSE:POLB)'s stock price today?
The current price of LSE:POLB is ÂŁ0.03. The 52 week high of LSE:POLB is ÂŁ0.16 and 52 week low is ÂŁ0.03.
When is next earnings date of Poolbeg Pharma PLC(LSE:POLB)?
The next earnings date of Poolbeg Pharma PLC(LSE:POLB) is 2025-04-30 Est..
Does Poolbeg Pharma PLC(LSE:POLB) pay dividends? If so, how much?
Poolbeg Pharma PLC(LSE:POLB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers